Home
Sands Capital Life Sciences Pulse Fund II reported a 6.1% stake in Alamar Biosciences ALMR · 4,230,926 sh · amendment
Trade details
- Type
- 5% stake report
- Report
- 13D · amendment
- Stake
- 6.1%
- Last report
- 6.3% · filed 26/04/23
- Shares held
- 4,230,926 sh
- Class
- Common Stock, par value $0.0001 per share
- Event date
- 26/07/05
- Filed
- 26/07/07
6.1% stake · −0.2pp from the last report
- Stake
- 6.1%
- Last report
- 6.3%
- Since last report
- −0.2pp
Alamar Biosciences trades, last 26 weeks
What else happened in Alamar Biosciences around then
Filed or reported within 30 days of the trade day · 06/05~08/04Sands Capital Life Sciences Pulse Fund II's other 5% stake reports
- Sands Capital Life Sciences Pulse Fund II
5% stakeInhibikase Therapeutics
5% stakeInhibikase Therapeutics
IKT
9.3% stake
13,018,965 sh
9.3% stake
Filed 08/13
- Sands Capital Life Sciences Pulse Fund II
5% stakeAcrivon Therapeutics
5% stakeAcrivon Therapeutics
ACRV
5.3% stake
2,289,271 sh
5.3% stake
Filed 08/13
- Sands Capital Life Sciences Pulse Fund II
5% stakeAlamar Biosciences
5% stakeAlamar Biosciences
ALMR
6.3% stake
4,230,926 sh
6.3% stake
Filed 04/23
- Sands Capital Life Sciences Pulse Fund II
5% stakeInhibikase Therapeutics
5% stakeInhibikase Therapeutics
IKT
10.8% stake
13,018,965 sh
10.8% stake
Filed 02/13
- Sands Capital Life Sciences Pulse Fund II
5% stakeBeta Bionics
5% stakeBeta Bionics
BBNX
7.3% stake
3,154,409 sh
7.3% stake
Filed 25/04/09